Pattern of Menorrhagic Female Attending the Hematology Unit in Assuit University Children Hospital
Launched by ASSIUT UNIVERSITY · Oct 24, 2024
Trial Information
Current as of July 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into the causes of heavy menstrual bleeding, known as menorrhagia, in adolescent girls aged 9 to 18 years old. The goal is to understand why some girls experience this condition, particularly focusing on blood-related issues, to improve how doctors manage abnormal bleeding during menstruation.
To participate, girls must be within the age range and must have heavy menstrual bleeding. However, those who are taking certain medications that affect blood clotting or have serious health problems like chronic lung, liver, or kidney diseases will not be eligible. Although the trial is not yet recruiting participants, it aims to help identify the underlying reasons for heavy menstrual bleeding and assist doctors in providing better care for these young patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - 1. Age of female patients range from (9 -18) years old.
- • 2. Girls with heavy menstrual bleeding
- Exclusion Criteria:
- • 1. Patients on medication affecting coagulation profile. 2. Patients with pre-existing illness as chronic lung, liver, renal disease or malignancy.
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported